Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 8:39 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2329–2352 of 3,983 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pathophysiology Clear all

Conditions: Mild Cognitive Impairment, Alzheimer's Disease
Interventions: Lighting Intervention; Device
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 50 Years and older
Enrollment: 73 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 2
States / cities: Albany, New York • New York, New York

Conditions: Pulmonary Disease, Pulmonary Hypertension
Interventions: Not listed
Lead sponsor: National Institutes of Health Clinical Center (CC); NIH
Eligibility: 18 Years to 100 Years
Enrollment: 270 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2013
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Healthy, NAFLD (Non-Alcoholic Fatty Liver Disease), NASH (Non-Alcoholic Steatohepatitis)
Interventions: NAFLD/NASH - Placebo, NAFLD/NASH - Vitamin E; Other · Dietary Supplement
Lead sponsor: Jeffrey Browning; Other
Eligibility: 18 Years to 65 Years
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2016
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Breast Cancer
Interventions: Not listed
Lead sponsor: Kettering Health Network; Other
Eligibility: 18 Years to 65 Years · Female only
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2011
U.S. locations: 2
States / cities: Dayton, Ohio • Kettering, Ohio

Conditions: Bowel Dysfunction, Constipation
Interventions: alvimopan, Placebo; Drug
Lead sponsor: Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA); Industry
Eligibility: 18 Years and older
Enrollment: 518 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 137
States / cities: Birmingham, Alabama • Calera, Alabama • Muscle Shoals, Alabama + 114 more

Conditions: Mild Cognitive Impairment (MCI), Alzheimer Disease
Interventions: The Canary Application; Other
Lead sponsor: Hackensack Meridian Health; Other
Eligibility: 50 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Hackensack, New Jersey

Conditions: Cognitive Impairment, Frail Elderly Syndrome
Interventions: Mini Cog; Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 70 Years and older
Enrollment: 229 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Mild Cognitive Impairment
Interventions: Planning for the Future, Enhanced Medical Engagement, Confidence Building and Social Engagement, Physical Intervention, Medical Adherence; Behavioral
Lead sponsor: Allison Gibson; Other
Eligibility: 18 Years and older
Enrollment: 38 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Gastroparesis, Gastroparesis Nondiabetic, Gastroparesis Due to Diabetes Mellitus Type I, Gastroparesis Due to Diabetes Mellitus Type II, Functional Disorder of Gastrointestinal Tract, Gastro-Intestinal Disorder
Interventions: Not listed
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 18 Years to 85 Years
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 6
States / cities: Scottsdale, Arizona • Louisville, Kentucky • Boston, Massachusetts + 3 more

Conditions: Major Depressive Disorder, Depression, Depressive Symptoms, Cardiovascular Disease (CVD), Coronary Artery Disease (CAD), Heart Disease
Interventions: Pentoxifylline, Placebo, Standard Treatment; Drug · Other · Behavioral
Lead sponsor: Indiana University; Other
Eligibility: 40 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Chronic Pancreatitis, Chronic Pain
Interventions: Mesenchymal stem cells, Placebo; Drug · Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 75 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Gulf War Syndrome
Interventions: Montelukast, Placebo; Drug · Other
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 50 Years to 70 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Mild Cognitive Impairment
Interventions: 11C-acetate; Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 65 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Congenital Heart Disease
Interventions: Partial Heart Transplantation, Freshly procured valve; Procedure · Other
Lead sponsor: Duke University; Other
Eligibility: Up to 12 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Mild Cognitive Impairment
Interventions: Strategy Training, Enhanced Usual Care; Behavioral · Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 60 Years and older
Enrollment: 105 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Chronic Pain, Low Back Pain, Fibromyalgia, Upper Extremity Dysfunction, Complex Regional Pain Syndromes, Phantom Limb Pain, Rheumatoid Arthritis, Carpal Tunnel Syndrome, Repetitive Strain Injury
Interventions: Karuna Labs Virtual Reality Software; Device
Lead sponsor: Karuna Labs Inc.; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Pulmonary Hypertension
Interventions: Ranolazine, Placebo; Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 80 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 3
States / cities: Baltimore, Maryland • Boston, Massachusetts • Philadelphia, Pennsylvania

Conditions: Microvascular Coronary Dysfunction
Interventions: Handgrip, Altitude simulation, Leg exercise; Other
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2030
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Sedentary Behavior, Cognitive Impairment
Interventions: Ecological Momentary Intervention; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 55 Years to 89 Years
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Cardiac Surgery, Post-operative Cognitive Dysfunction, Fever
Interventions: Rapr Rounds Hyper/Hypothermia Wraps, Acetaminophen; Device · Drug
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 20 Years to 89 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Cognitive Measures, Driving Simulator Performance
Interventions: Phenytoin, Placebo oral capsule; Drug
Lead sponsor: University of Iowa; Other
Eligibility: 25 Years to 60 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Bone Marrow Failure Syndrome, Thalassemia, Sickle Cell Disease, Diamond Blackfan Anemia, Acquired Neutropenia in Newborn, Acquired Anemia Hemolytic, Acquired Thrombocytopenia, Hemophagocytic Lymphohistiocytoses, Wiskott-Aldrich Syndrome, Chronic Granulomatous Disease, Common Variable Immunodeficiency, X-linked Lymphoproliferative Disease, Severe Combined Immunodeficiency, Hurler Syndrome, Mannosidosis, Adrenoleukodystrophy
Interventions: Thiotepa--single daily dose, Thiotepa--escalated dose; Drug
Lead sponsor: University of Florida; Other
Eligibility: 3 Months to 39 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Cognitive Decline
Interventions: Lion's Mane Study Product; Dietary Supplement
Lead sponsor: M2 Ingredients; Industry
Eligibility: 40 Years to 75 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Erectile Dysfunction
Interventions: Sildenafil; Drug
Lead sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.; Industry
Eligibility: 18 Years to 55 Years · Male only
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008
U.S. locations: 1
States / cities: New Haven, Connecticut

Search by objective public record fields.

The Long-term Impact of a Light Intervention on Sleep and Cognition in Mild Cognitive Impairment

Natural History Study of Biomarkers in Pulmonary Arterial Hypertension

Effect of Vitamin E on Non-Alcoholic Fatty Liver Disease

Magnetic Resonance Imaging (MRI) of Tumor Response and Cognitive Impairment in Breast Cancer Patients Undergoing Chemotherapy

Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain

Speech-derived Digital Biomarkers Study

Preoperative Cognitive Screening in Older Spinal Surgical Patients

Platform-based Mild Cognitive Impairment (MCI) Trial

Gastroparesis Registry 4

Anti-INFLammatory to Address Mood and Endothelial Dysfunction (INFLAMED)

Novel Cellular Therapy for the Treatment of Pain Associated With Chronic Pancreatitis

Clinical Evaluation of Montelukast in Veterans With Gulf War Illness

11C-Acetate PET/CT Imaging As a Biomarker of Amyloid-Induced Neuroinflammation

Partial Heart Transplantation

Facilitating Optimal Routines in Aging

Research Protocol for Karuna Labs Inc.: Safety and Efficacy of Virtual Reality Graded Motor Imagery for Chronic Pain

Targeting Right Ventricle in Pulmonary Hypertension Gilead

Development of a Novel Stress Testing Protocol to Define the Relationship Between Coronary Microvascular Dysfunction and Diastology in Women With Angina But No Evidence of Obstructive Coronary Artery Disease

A Physical Activity Program to Disrupt Sedentary Time in Older Latinos

Active Temperature Management After Cardiac Surgery and Its Effect on Postoperative Cognitive Dysfunction

Phenytoin and Driving Safety: A Randomized, Controlled Cross-Over Study

Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation

Study Evaluating the Quality and Effects of Lion's Mane Product on Cognitive Health

A Study to Compare the Blood Levels of Sildenafil Following Administration of an Experimental Tablet vs. the Conventional Oral Tablet in Healthy Subjects